Pal-ing, Jeneva M.
HRN: 26-79-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
03/21/2025
03/28/2025
PO
30ml
TID
SLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes